A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata

Fertility and Sterility

Volumn 70, Issue 1, 1998, Pages 111-118

  Palomba, Stefano ^a,b   Affinito, Pietro ^a   Tommaselli, Giovanni A ^a   Nappi, Carmine ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

Add back therapy; GnRH a; Tibolone; Uterine leiomyomata

Indexed keywords

CHOLESTEROL; GONADORELIN DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEUPRORELIN; TIBOLONE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; CHOLESTEROL BLOOD LEVEL; CLIMACTERIUM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ECHOGRAPHY; FEMALE; HOT FLUSH; HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TUMOR VOLUME; UTERUS MYOMA; VAGINA BLEEDING;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; CLIMACTERIC; DOUBLE-BLIND METHOD; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LEIOMYOMA; LIPIDS; MUSCLE, SMOOTH, VASCULAR; NORPREGNENES; PROSPECTIVE STUDIES; UTERINE NEOPLASMS;

EID: 0032125471     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00128-9     Document Type: Article

References (25)

1. 1. Belchetz PE, Plant TM, Nakai Y, Keogh EJ, Knobil E. Hypophyseal responses to continuous and intermittent delivery of hypothalamic gonadotropin releasing hormone. Science 1978;202:631-7.
2. 2. Rutgers JL, Spong CY, Sinow R, Heiner J. Leuprolide acetate treatment and myoma arterial size. Obstet Gynecol 1995;86:386-8.
3. 3. Adashi EY. Long-term gonadotropin releasing hormone agonist therapy: the evolving issue of steroidal "add-back" paradigms. Hum Reprod 1994;9:1380-97.
4. 4. Surrey ES. Steroidal and nonsteroidal "add-back" therapy: extending safety and efficacy of gonadotropin-releasing hormone agonist in the gynecologic patient. Fertil Steril 1995;64:673-85.
5. 5. Ross LA, Alder EM. Tibolone and climacteric symptoms. Maturitas 1995;21:127-36.
6. 6. Riggs BL. Tibolone as an alternative to estrogen for the prevention of postmenopausal osteoporosis in selected postmenopausal women. J Clin Endocrinol Metab 1996;81:2417-8.
7. 7. Nathorst-Boos J, Hammar M. Effect on sexual life. A comparison between tibolone and a continuous estradiol-norethisterone acetate regimen. Maturitas 1997;26:15-20.
8. 8. Palacios S, Menendez C, Jurado AR, Castano R, Vargas JC. Changes in sex behavior after menopause: effects of tibolone. Maturitas 1995;22: 155-61.
9. 9. Affinito P, Sorrentino C, Farace MJ, Di Carlo C, Moccia GF, Canciello P, et al. Effects of thyroxine therapy on bone metabolism in postmenopausal women with hypothyroidism. Acta Obstet Gynecol Scand 1996; 75:843-8.
10. 10. Affinito P, Tommaselli GA, Di Carlo C, Guida F, Nappi C. Changes in bone mineral density and calcium metabolism in breastfeeding women: a one year follow-up study. J Clin Endocrinol Metab 1996;81:2314-23.
11. 11. Lupoli G, Di Carlo C, Nuzzo V, Vitale G, Russo D, Palomba S, et al. Gonadotropin-releasing hormone agonists administration in polycystic ovary syndrome. Effects on bone mass. J Endocrinol Invest 1997;20: 493-6.
12. 12. Monroe SE, Blumenfeld Z, Andreyko JL, Schriock E, Henzl MR, Jaffrey RB. Dose-dependent inhibition of pituitary-ovarian function during administration of gonadotropin-releasing hormone agonist analog (nafarelin). J Clin Endocrinol Metab 1986;63:1334-41.
13. 13. Paoletti AM, Serra GG, Cagnacci A, Vacca AM, Guerriero S, Solla E, et al. Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment. Fertil Steril 1996;65:707-10.
14. 14. Revilla R, Revilla M, Hernandez ER, Villa LF, Varela L, Rico H. Evidence that the loss of bone mass induced by GnRH agonist is not totally recovered. Maturitas 1995;22:145-50.
15. 15. Friedman AJ, Daly M, Juneau-Norcross M, Rein MS, Fine C, Gleason R, et al. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri. J Clin Endocrinol Metab 1993;76:1439-45.
16. 16. Surrey ES, Voigt B, Fournet N, Judd HL. Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone "add-back" therapy. Fertil Steril 1995;63:747-55.
17. 17. Lindsay PC, Shaw RW, Bennink HJ, Kicovic P. The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl). Fertil Steril 1996;65:342-8.
18. 18. Dodin S, Lemay A, Maheux R, Dumont M, Turcot-Lemay L. Bone mass in endometriosis patients treated with GnRH agonist implant or danazol. Obstet Gynecol 1991;77:410-5.
19. 19. Dawood MY, Lewis V, Ramos J. Cortical and trabecular bone mineral content in women with endometriosis: effect of gonadotropin-releasing hormone agonist and danazol. Fertil Steril 1989;52:21-6.
20. 20. Compston JE, Yamaguchi K, Croucher PI, Garrahan NJ, Lindsay PC, Shaw RW. The effects of gonadotropin-releasing hormone agonist on iliac crest cancellous bone structure in women with endometriosis. Bone 1995;16:261-7.
21. 21. Farish E, Barnes JF, Rolton HA, Spowart K, Fletcher CD, Hart DM. Effects of tibolone on lipoprotein (a) and HDL subfractions. Maturitas 1994;20:215-9.
22. 22. Hanggi W, Lippuner K, Riesen W, Jaeger P, Birkhauser MH. Long-term influence of different postmenopausal hormone replacement regimens on serum lipids and lipoprotein (a): a randomized study. Br J Obstet Gynaecol 1997;104:708-17.
23. 23. Milner MH, Sinnott MM, Cooke TM, Kelly A, McGill T, Harrison RF. A 2-year study of lipid and lipoprotein changes in postmenopausal women with tibolone and estrogen-progestin. Obstet Gynecol 1996;87:593-9.
24. 24. Bjarnason NH, Bjarnason K, Haarbo J, Bennink HJ, Christiansen C. Tibolone: influence on markers of cardiovascular disease. J Clin Endocrinol Metab 1997;82:1752-6.
25. 25. Cagnacci A, Mallus E, Tuveri F, Cirillo R, Setteneri AM, Melis GB. Effect of tibolone on glucose and lipid metabolism in postmenopausal women. J Clin Endocrinol Metab 1997;82:251-3.